Making New Drugs With a Dose of Artificial Intelligence - The New York Times

Making New Drugs With a Dose of Artificial Intelligence  The New York Times

Researchers at DeepMind, owned by Google's parent company, and other companies are applying their powerful A.I. systems to drug discovery research.